This compromised shutdown mechanism compounds the feedback disruption driven by NR3C1 loss, fueling a persistent neuroendocrine imbalance that mirrors the abnormalities consistently reported in patients diagnosed with MDD. The gene discussed is NR3C1; the disease is major depressive disorder.